Jeryl L. Hilleman - 05 Jul 2026 Form 4/A - Amendment Insider Report for Omada Health, Inc. (OMDA)

Reporting relationship: Director
Issuer ticker: OMDA
Reported as of: 05 Jul 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 20 Jul 2026, 19:16:33 UTC
Original report date: 07 Jul 2026
Prior SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman

Key filing fact

Jeryl L. Hilleman filed Form 4/A - Amendment for Omada Health, Inc. (OMDA) on 20 Jul 2026.

Key facts

This page summarizes Jeryl L. Hilleman's Form 4/A - Amendment filing for Omada Health, Inc. (OMDA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Jul 2026, 19:16.

Change

Previous filing in this sequence was filed on 18 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001216628 Primary reporting owner

HILLEMAN JERYL L

Relationship: Director
Address: C/O OMADA HEALTH, INC., 611 GATEWAY BLVD., SUITE 120, SOUTH SAN FRANCISCO
Signature: /s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman
Signature date: 20 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OMDA transaction

Common Stock

Award

Transaction value
Shares: +1,435
Change %: +5.7%
Price: $0.000000^*
Shares after: 26,655
Date: 05 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

Footnote F2

This Form 4/A is being filed solely to correct the number of RSUs reported as granted on July 5, 2026, and the total number of shares beneficially owned by the Reporting Person. Due to an administrative error, the original Form 4 filing understated the number of RSUs that were granted pursuant to the Program. This amendment corrects the error to reflect the actual number of RSUs granted and the shares beneficially owned by the Reporting Person following the grant.